首页> 外文期刊>Reproductive Biology and Endocrinology >Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women
【24h】

Association of three missense mutations in the homocysteine-related MTHFR and MTRR gene with risk of polycystic ovary syndrome in Southern Chinese women

机译:南方南方女性多囊卵巢综合征风险的三种畸形突变与MTRR基因的关联

获取原文
           

摘要

The etiology between homocysteine and polycystic ovary syndrome (PCOS) is unclear. In humans, the level of homocysteine is mainly affected by two enzymes: methylene tetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR). While the activity of these two enzymes is mainly affected by three missense mutations, namely C677T (MTHFR), A1298C (MTHFR), and A66G (MTRR). This study aims to examine the association between the three missense mutations and PCOS and investigate whether the three missense mutations exerted their effect on PCOS by affecting the homocysteine level. A case-control study was designed, comprising 150 people with PCOS and 300 controls. Logistic regression analysis was used to assess the association between the three missense mutations and PCOS. Linear regression analysis was used to assess the association between the three missense mutations and the homocysteine level. Mediation analysis was used to investigate whether the three missense mutations exerted their effect on PCOS by affecting the homocysteine level. Following adjustments and multiple rounds of testing, MTHFR A1298C was found to be significantly associated with PCOS in a dose-dependent manner (compared to AA, OR?=?2.142 for AC & OR?=?3.755 for CC; P??0.001). MTRR A66G was nominally associated with PCOS. Mutations in MTHFR A1298C and MTRR A66G were significantly associated with the homocysteine level. Mediation analysis suggested the effect of MTHFR A1298C on PCOS was mediated by homocysteine. MTHFR A1298C and MTRR A66G were associated with PCOS, and MTHFR A1298C might affect the risk of PCOS by influencing the homocysteine level.
机译:同型半胱氨酸和多囊卵巢综合征(PCOS)之间的病因尚不清楚。在人类中,同型半胱氨酸的水平主要受两种酶:亚甲基四氢溶胶还原酶(MTHFR)和甲硫氨酸合成酶还原酶(MTRR)。虽然这两种酶的活性主要受三个畸形突变的影响,即C677T(MTHFR),A1298C(MTHFR)和A66G(MTRR)。本研究旨在检查三个畸形突变和PCO之间的关联,并调查三个畸形突变是否通过影响同型半胱氨酸水平对PCOS的作用。设计了一个案例对照研究,包括150名具有PCOS和300控制的人。 Logistic回归分析用于评估三个畸形突变与PCO之间的关联。线性回归分析用于评估三个畸形突变与同型突变水平之间的关联。使用中介分析来研究三种畸形突变是否通过影响同型半胱氨酸水平来施加对PCOS的影响。在调整和多轮测试之后,发现MTHFR A1298C以剂量依赖性方式显着与PCOS相关联(与AA相比,或Δ=Δ2.1.142,用于CC; P?P?<3.7 0.001)。 MTRR A66G名义上与PCOS相关联。 MTHFR A1298C和MTRR A66G中的突变与同型半胱氨酸水平显着相关。调解分析表明MTHFR A1298C对PCOS的影响是由同型胱内膜介导的。 MTHFR A1298C和MTRR A66G与PCOS相关,MTHFR A1298C可能会影响PCOS的风险,通过影响同型半胱氨酸水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号